查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429875

2024 年多重檢測全球市場報告

Multiplex Assays Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

多重檢測的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 9.5% 的年複合成長率（CAGR）成長至 57 億美元。預測期內的預期成長是由於資金增加、政府對遺傳和微生物研究的承諾、人口老齡化、慢性病患病率上升以及各種細菌和病毒患病率迅速上升。增加預測期內預計的主要趨勢包括資金激增、政府在遺傳和微生物研究方面的持續努力、人口老齡化的影響、慢性病患病率的增加以及各種細菌和病毒患病率的迅速上升. 包括增加。

由於慢性病盛行率的增加，全球多重檢測市場正在成長。多重檢測廣泛應用於疾病分析、療效研究和抗體檢測等臨床試驗。根據世界衛生組織 (WHO) 2021 年 4 月的報告，非傳染性疾病 (NCD) 每年導致 4,100 萬人死亡，佔全球死亡人數的 71%。與傳統方法相比，慢性病發病率的上升以及多重檢測提供的快速分析預計將在預測期內推動市場成長。

隨著政府和私人組織資助的增加，多重檢測市場預計將進一步成長。人們正在對多重檢測的開發進行大量投資，特別是在面對 COVID-19感染疾病的挑戰的情況下。 COVID-19 檢測的激增導致了整合和合併活動，例如羅氏於 2021 年 3 月收購了 GenMark Diagnostics，以增強其多重檢測能力。 Thermo Fisher Scientific 計劃於 2021 年 1 月收購 Mesa Biotech 和 PerkinElmer 收購 Oxford Immunities 就是因更關注多重技術開發而採取的策略舉措的例子。資金籌措的增加預計將對多重檢測市場產生正面影響。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球多重檢測市場的驅動與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球多重檢測市場規模、表現與成長
  • 全球多重檢測市場規模與成長預測，2023-2028 年、2033 年

第6章市場區隔

  • 全球多重檢測市場，按類型、實際和預測細分，2018-2023、2023-2028、2033
  • 基於蛋白質的多重檢測
  • 基於核酸的多重檢測
  • 其他
  • 全球多重檢測市場，按識別技術、性能和預測細分，2018-2023、2023-2028、2033
  • 流式細胞技術
  • 多重即時PCR
  • 其他識別技術
  • 多重即時PCR
  • 其他
  • 全球多重檢測市場，按應用細分、實際情況和預測，2018-2023、2023-2028、2033
  • 研究與開發
  • 藥物發現與開發
  • 生物標記的發現與檢驗
  • 臨床診斷
  • 全球多重檢測市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 製藥和生物技術公司
  • 醫院及研究所
  • 參考實驗室
  • 其他

第 7 章 區域與國家分析

  • 全球多重檢測市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球多重檢測市場，按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 多重檢測市場的競爭形勢
  • 多重檢測市場公司概況
    • Seegene Inc
    • DiaSorin SpA
    • Thermo Fisher Scientific Inc
    • Bio-Rad Laboratories Inc
    • Qiagen NV

第31章 其他大型創新公司

  • Abcam Plc
  • PerkinElmer Inc
  • Hologic Corporation
  • Meso Scale Diagnostics
  • Merck KGaA
  • Roche Diagnostics India Pvt Ltd
  • bioMerieux India
  • Becton Dickinson Private Limited
  • Danaher Corporation
  • Johnson &Johnson
  • Simens Healthcare
  • Beckman Coulter Inc. India
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Siemens Healthineers Ukraine

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與潛力分析

第36章附錄

簡介目錄
Product Code: r14846

Multiplex assays are employed to amplify multiple targets in a polymerase chain reaction (PCR) trial, enabling the extraction of additional information from minuscule amounts of proteins or other analyses in a shorter time compared to traditional systems, similar to ELISA. These assays find application in pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and other scientific endeavors.

The primary types of multiplex assays comprise nucleic acid-based multiplex assays, protein-based multiplex assays, and others. Nucleic acid-based multiplex assays rely on nucleic acids to detect organism-specific DNA or RNA sequences. These tests are generally characterized by specificity and high sensitivity, providing rapid results. Various technologies underpin multiplex assays, including flow cytometry, luminescence, fluorescence detection, multiplex real-time PCR, and other related technologies. Multiplex assays serve diverse applications, including research and development, as well as clinical diagnostics. End-users encompass pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories, and other entities involved in scientific research and diagnostics.

The multiplex assays market research report is one of a series of new reports from The Business Research Company that provides multiplex assays market statistics, including multiplex assays industry global market size, regional shares, competitors with multiplex assays market share, detailed multiplex assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex assays industry. This multiplex assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The multiplex assays market size has grown strongly in recent years. It will grow from $3.61 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The expansion observed in the historical period can be attributed to increased healthcare expenditure, growth in emerging markets, rapid technological advances, and a significant increase in the aging population.

The multiplex assays market size is expected to see strong growth in the next few years. It will grow to $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to the increase in funding, government initiatives for genetic and microbiological research, the aging population, the rising prevalence of chronic diseases, and a rapid increase in various bacterial and viral epidemics. Key trends projected for the forecast period include a surge in funding, continued government initiatives for genetic and microbiological research, the impact of an aging population, the growing prevalence of chronic diseases, and a rapid rise in various bacterial and viral epidemics.

The global multiplex assay market is witnessing growth driven by an increased prevalence of chronic diseases. Multiplex assays are widely utilized in clinical trials for disease analysis, studying efficacy, and detecting antibodies. According to the World Health Organization (WHO) report from April 2021, non-communicable diseases (NCDs) cause 41 million deaths annually, accounting for 71% of global deaths. The rising incidence of chronic diseases, coupled with the faster analysis offered by multiplex assays compared to traditional methods, is anticipated to propel market growth in the forecast period.

The market for multiplex assays is expected to be further driven by increased funding from governments and private organizations. Significant investments are being made to develop multiplex assays, especially amid the challenges posed by the COVID-19 pandemic. The surge in COVID-19 testing has led to consolidation and merger activities, such as Roche's acquisition of GenMark Diagnostics in March 2021 to enhance multiplex testing capabilities. Thermo Fisher Scientific's plans to acquire Mesa Biotech and PerkinElmer's acquisition of Oxford Immunities in January 2021 are examples of strategic moves driven by the increased focus on multiplex technology development. This rise in funding is anticipated to have a positive impact on the multiplex assay market.

Companies in the market are actively launching innovative tests based on multiplex assays to fortify their market positions. In May 2022, QuantuMDx Group Limited introduced the Q-POC SARS-CoV-2, Flu A/B, and RSV Assay, a multiplex panel designed to detect SARS-CoV-2, Influenza A, Influenza B, and RSV at the point of need, further showcasing the market's evolution.

New product launches remain a key strategy for companies in the multiplex assay market to enhance their market presence. Euro Fins Technologies, for instance, launched two RT-PCR assays in 2021 capable of accurately diagnosing respiratory diseases caused by SARS-CoV-2, Influenza virus, or RSV. These CE-marked multiplex kits can identify and distinguish between three distinct viral infections in a single PCR run, simplifying the detection process.

In May 2021, Roche acquired GenMark for $1.8 billion, expanding its molecular diagnostics portfolio in syndromic testing. GenMark Diagnostics, a multiplex molecular diagnostic solutions provider, focuses on improving patient care, enhancing quality metrics, and reducing the overall cost of care. This strategic move underscores the growing importance of multiplex assays in advancing diagnostic capabilities and meeting healthcare challenges.

Major companies operating in the multiplex assays market report are Seegene Inc., DiaSorin SpA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen NV, Abcam PLC, PerkinElmer Inc., Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd., bioMerieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Dexcom Inc., Medtronic Inc., Senseonics Holdings Inc., Adavium Medical, DK Diagnostics, Crosmed, Ortopedia Alemana, Simed, Ab Enzymes Gmbh, Bluestar Adisseo Co., BASF SE, Chr. Hansen Holding, Novozymes, BiotechAfrica, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc., The Merck Group, Takara Bio Inc., Qiagen, Spherotech Inc., Geneaid Biotech Ltd., Rockland Immunochemicals Inc., GenScript Biotech Corporation

North America was the largest region in the multiplex assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The multiplex assays market consists of sales of equipment with technologies that can detect multiple genes such as flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, and other technologies in multiplex assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex Assays Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex assays? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiplex assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Protein-Based Multiplex Assays; Nucleic Acid-Based Multiplex Assays; Other Types
  • 2) By Identification Technology: Flow Cytometry; Multiplex Real-Time PCR; Other Identification Technologies
  • 3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Luminescence; Fluorescence; Other Detection Technologies
  • 4) By Application: Research And Development; Clinical Diagnostics
  • 5) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Research Institutes; Reference Laboratories; Other End-Users
  • Companies Mentioned: Seegene Inc; DiaSorin SpA; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; Qiagen NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex Assays Market Characteristics

3. Multiplex Assays Market Trends And Strategies

4. Multiplex Assays Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Multiplex Assays Market Size and Growth

  • 5.1. Global Multiplex Assays Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Multiplex Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Multiplex Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Multiplex Assays Market Segmentation

  • 6.1. Global Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Protein-Based Multiplex Assays
  • Nucleic Acid-Based Multiplex Assays
  • Other Types
  • 6.2. Global Multiplex Assays Market, Segmentation By Identification Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Flow Cytometry
  • Multiplex Real-Time PCR
  • Other Identification Technologies
  • Multiplex Real-Time PCR
  • Other Technologies
  • 6.3. Global Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research And Development
  • Drug Discovery And Development
  • Biomarker Discovery And Validation
  • Clinical Diagnostic
  • 6.4. Global Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Research Institutes
  • Reference Laboratories
  • Other End Users

7. Multiplex Assays Market Regional And Country Analysis

  • 7.1. Global Multiplex Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Multiplex Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Multiplex Assays Market

  • 8.1. Asia-Pacific Multiplex Assays Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Multiplex Assays Market

  • 9.1. China Multiplex Assays Market Overview
  • 9.2. China Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Multiplex Assays Market

  • 10.1. India Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Multiplex Assays Market

  • 11.1. Japan Multiplex Assays Market Overview
  • 11.2. Japan Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Multiplex Assays Market

  • 12.1. Australia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Multiplex Assays Market

  • 13.1. Indonesia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Multiplex Assays Market

  • 14.1. South Korea Multiplex Assays Market Overview
  • 14.2. South Korea Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Multiplex Assays Market

  • 15.1. Western Europe Multiplex Assays Market Overview
  • 15.2. Western Europe Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Multiplex Assays Market

  • 16.1. UK Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Multiplex Assays Market

  • 17.1. Germany Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Multiplex Assays Market

  • 18.1. France Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Multiplex Assays Market

  • 19.1. Italy Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Multiplex Assays Market

  • 20.1. Spain Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Multiplex Assays Market

  • 21.1. Eastern Europe Multiplex Assays Market Overview
  • 21.2. Eastern Europe Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Multiplex Assays Market

  • 22.1. Russia Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Multiplex Assays Market

  • 23.1. North America Multiplex Assays Market Overview
  • 23.2. North America Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Multiplex Assays Market

  • 24.1. USA Multiplex Assays Market Overview
  • 24.2. USA Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Multiplex Assays Market

  • 25.1. Canada Multiplex Assays Market Overview
  • 25.2. Canada Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Multiplex Assays Market

  • 26.1. South America Multiplex Assays Market Overview
  • 26.2. South America Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Multiplex Assays Market

  • 27.1. Brazil Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Multiplex Assays Market

  • 28.1. Middle East Multiplex Assays Market Overview
  • 28.2. Middle East Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Multiplex Assays Market

  • 29.1. Africa Multiplex Assays Market Overview
  • 29.2. Africa Multiplex Assays Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Multiplex Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Multiplex Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Multiplex Assays Market Competitive Landscape And Company Profiles

  • 30.1. Multiplex Assays Market Competitive Landscape
  • 30.2. Multiplex Assays Market Company Profiles
    • 30.2.1. Seegene Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. DiaSorin SpA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bio-Rad Laboratories Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Qiagen NV
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Multiplex Assays Market Other Major And Innovative Companies

  • 31.1. Abcam Plc
  • 31.2. PerkinElmer Inc
  • 31.3. Hologic Corporation
  • 31.4. Meso Scale Diagnostics
  • 31.5. Merck KGaA
  • 31.6. Roche Diagnostics India Pvt Ltd
  • 31.7. bioMerieux India
  • 31.8. Becton Dickinson Private Limited
  • 31.9. Danaher Corporation
  • 31.10. Johnson & Johnson
  • 31.11. Simens Healthcare
  • 31.12. Beckman Coulter Inc. India
  • 31.13. Ortho Clinical Diagnostics
  • 31.14. Sysmex Corporation
  • 31.15. Siemens Healthineers Ukraine

32. Global Multiplex Assays Market Competitive Benchmarking

33. Global Multiplex Assays Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Multiplex Assays Market

35. Multiplex Assays Market Future Outlook and Potential Analysis

  • 35.1 Multiplex Assays Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Multiplex Assays Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Multiplex Assays Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer